Nanocarry
Rachela Popovtzer is currently serving as the Vice Dean at Bar Ilan University in the Faculty of Engineering. Rachela has also worked as a Member at 8400 - The Health Network and as a Visiting Professor at Memorial Sloan Kettering Cancer Center. Additionally, Rachela has held various roles at the University of Michigan and Bar-Ilan University, including Post Doc, Full Professor, Head of the Bioengineering Track, Associate Professor, and Assistant Professor.
This person is not in any offices
Nanocarry
Nanocarry is developing a new class of therapeutics based on bioengineered nanoparticles with novel capabilities to treat oncology indications and brain diseases. Using a proprietary “Plug and Play” approach, Nanocarry’s AxS platform can be easily modified to deliver a wide array of biologics, safely and effectively, to the brain and beyond. Nanocarry’s first products in development are for brain metastases of HER2+ breast cancer and non-small cell lung cancer.